Patents by Inventor William H. Robinson

William H. Robinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11933571
    Abstract: Provided herein are buffer systems, bolt assemblies, firearms, and related methods, devices, and assemblies. A bolt carrier assembly for a firearm of an example includes: a bolt carrier body defining a cavity extending along a longitudinal axis of the bolt carrier; at least one weight disposed within the cavity; a forward stop at a forward end of the cavity; and an aft stop at an aft end of the cavity. In some embodiments, the bolt carrier assembly may include a spring, where the spring biases the at least one weight along the longitudinal axis toward at least one of the forward stop or the aft stop, where the at least one weight is configured to be driven against the spring bias in response to a firing action of the firearm.
    Type: Grant
    Filed: July 15, 2022
    Date of Patent: March 19, 2024
    Assignee: WHG PROPERTIES, LLC
    Inventors: Frank Eric Robinson, William H. Geissele
  • Publication number: 20240035019
    Abstract: Disclosed herein are compositions and methods for sequencing, analyzing, and utilizing samples such as single samples. Also disclosed herein are compositions and methods for matching together two or more sequences from a sample. Also disclosed herein are compositions and methods for expressing and screening molecules of interest.
    Type: Application
    Filed: June 28, 2018
    Publication date: February 1, 2024
    Inventors: William H. Robinson, Yann Chong Tan, Jeremy Sokolove
  • Publication number: 20230391857
    Abstract: The CD47 mimic protein of Borrelia burgdorferi is identified as p66 protein. Blocking the p66 protein on the pathogen Improves the immune response of an infected individual, and allows a more complete and/or more rapid resolution of Borrelia infection. The disclosure provides a method of inhibiting or treating an infection by a Borrelia pathogen, the method comprising administering an effective amount of an anti-p66 agent that reduces binding of p66 on the pathogen to signal regulatory protein a (SIRPa) on a phagocytic cell, where the agent (i) specifically binds to p66, or (ii) is a p66 polypeptide or derivative thereof.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 7, 2023
    Inventors: Michal Caspi Tal, Balyn Zaro, Irving L. Weissman, Nitya Ramadoss, William H. Robinson
  • Publication number: 20230287392
    Abstract: Disclosed herein are compositions and methods for sequencing, analyzing, and utilizing samples such as single samples. Also disclosed herein are compositions and methods for matching together two or more sequences from a sample. Also disclosed herien are compositions and methods for expressing and screening molecules of interest.
    Type: Application
    Filed: August 3, 2021
    Publication date: September 14, 2023
    Inventors: William H. Robinson, Yann Chong Tan, Jeremy Sokolove
  • Publication number: 20230140035
    Abstract: Provided herein are antibodies that bind to tumor tissue through a binding interaction with an extracellular RNA-protein complex. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.
    Type: Application
    Filed: September 26, 2022
    Publication date: May 4, 2023
    Inventors: Jeff DeFalco, Daniel Eric Emerling, Jessica Finn, Norman Michael Greenberg, Vera Huang, Shaun M. Lippow, Fengling Liu, Amy Manning-Bog, William H. Robinson, Alexander Scholz, Tito Serafini, Nikhil Vad, Wayne Volkmuth, Yann Chong TAN
  • Patent number: 11472885
    Abstract: Provided herein are antibodies that bind to tumor tissue through a binding interaction with an extracellular RNA-protein complex. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: October 18, 2022
    Assignee: Atreca, Inc.
    Inventors: Jeff DeFalco, Daniel Eric Emerling, Jessica Finn, Norman Michael Greenberg, Vera Huang, Shaun M. Lippow, Fengling Liu, Amy Manning-Bog, William H. Robinson, Alexander Scholz, Tito Serafini, Yann Chong Tan, Nikhil Vad, Wayne Volkmuth
  • Patent number: 11098302
    Abstract: Disclosed herein are compositions and methods for sequencing, analyzing, and utilizing samples such as single samples. Also disclosed herein are compositions and methods for matching together two or more sequences from a sample. Also disclosed herein are compositions and methods for expressing and screening molecules of interest.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: August 24, 2021
    Assignees: The Board of Trustees of the Leland Stanford Junior University, The United States Government as Represented by the Department of Veterans Affair
    Inventors: William H. Robinson, Yann Chong Tan, Jeremy Sokolove
  • Publication number: 20200325242
    Abstract: Provided herein are antibodies that bind to tumor tissue through a binding interaction with an extracellular RNA-protein complex. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.
    Type: Application
    Filed: February 14, 2020
    Publication date: October 15, 2020
    Inventors: Jeff DeFalco, Daniel Eric Emerling, Jessica Finn, Norman Michael Greenberg, Vera Huang, Shaun M. Lippow, Fengling Liu, Amy Manning-Bog, William H. Robinson, Alexander Scholz, Tito Serafini, Yann Chong Tan, Nikhil Vad, Wayne Volkmuth
  • Publication number: 20200206227
    Abstract: Methods of treating mast cell-mediated inflammatory diseases are provided by local administration a therapeutically effective amount of a tyrosine kinase inhibitor to a patient in need thereof.
    Type: Application
    Filed: November 1, 2019
    Publication date: July 2, 2020
    Inventors: William H. Robinson, Anna Postolova, Harini Raghu
  • Publication number: 20190315827
    Abstract: The present invention provides compositions and methods for treating insulin-dependent diabetes mellitus in a subject comprising administration of a self-vector encoding and expressing human proinsulin.
    Type: Application
    Filed: November 21, 2018
    Publication date: October 17, 2019
    Applicant: Tolerion, Inc.
    Inventors: Bart O. Roep, William H. Robinson, Paul Utz, Hideki Garren, Lawrence Steinman
  • Publication number: 20180311231
    Abstract: Compositions and methods are provided for inhibiting or treating the early and established stages of inflammatory diseases by administration of an effective dose of the desethylhydroxychloroquine (DHCQ). A benefit of the methods is the ability to deliver a dose of agent that is effective in treating inflammation while sparing the individual from retinal toxicity.
    Type: Application
    Filed: February 21, 2018
    Publication date: November 1, 2018
    Inventors: William H. Robinson, Jeremy Sokolove, Qian Wang
  • Publication number: 20180155411
    Abstract: Compositions and methods are provided relating to rotavirus serotypes and antibodies that bind to human rotavirus and modifications thereto which enhance the immunogenicity of the rotavirus protein for vaccine development with respect to the generation of a neutralizing immune response. Further disclosed are methods of using the antibodies for treating a rotavirus-mediated disease in a subject.
    Type: Application
    Filed: July 8, 2016
    Publication date: June 7, 2018
    Inventors: Nitya Nair, Lisa Blum, Ningguo Feng, William H. Robinson, Harry Greenberg, Mrinmoy Sanyal
  • Patent number: 9931335
    Abstract: Compositions and methods are provided for inhibiting or treating the early and established stages of inflammatory diseases by administration of an effective dose of the desethylhydroxychloroquine (DHCQ). A benefit of the methods is the ability to deliver a dose of agent that is effective in treating inflammation while sparing the individual from retinal toxicity.
    Type: Grant
    Filed: March 1, 2017
    Date of Patent: April 3, 2018
    Assignees: The Board of Trustees of the Leland Stanford Junior University, The United States of America as Represented by the Department of Veterans Affairs
    Inventors: William H. Robinson, Jeremy Sokolove, Qian Wang
  • Publication number: 20170312282
    Abstract: Methods of treating mast cell-mediated inflammatory diseases are provided by local administration a therapeutically effective amount of a tyrosine kinase inhibitor to a patient in need thereof.
    Type: Application
    Filed: April 28, 2017
    Publication date: November 2, 2017
    Inventors: William H. Robinson, Anna Postolova, Harini Raghu
  • Publication number: 20170172998
    Abstract: Compositions and methods are provided for inhibiting or treating the early and established stages of inflammatory diseases by administration of an effective dose of the desethylhydroxychloroquine (DHCQ). A benefit of the methods is the ability to deliver a dose of agent that is effective in treating inflammation while sparing the individual from retinal toxicity.
    Type: Application
    Filed: March 1, 2017
    Publication date: June 22, 2017
    Inventors: William H. Robinson, Jeremy Sokolove, Qian Wang
  • Patent number: 9616057
    Abstract: Compositions and methods are provided for inhibiting or treating the early and established stages of inflammatory diseases by administration of an effective dose of the desethylhydroxychloroquine (DHCQ). A benefit of the methods is the ability to deliver a dose of agent that is effective in treating inflammation while sparing the individual from retinal toxicity.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: April 11, 2017
    Assignees: The Board of Trustees of the Leland Stanford Junior University, The United States of America as Represented by the Department of Veterans Affairs
    Inventors: William H. Robinson, Jeremy Sokolove, Qian Wang
  • Publication number: 20160146831
    Abstract: Compositions and methods are provided for prognostic classification of autoimmune disease patients into subtypes, which subtypes are informative of the patient's need for therapy and responsiveness to a therapy of interest. The patterns of circulating blood levels of serum autoantibodies and/or cytokines provides for a signature pattern that can identify patients likely to benefit from therapeutic intervention as well as discriminate patients that have a high probability of responsiveness to a therapy from those that have a low probability of responsiveness. Additionally, serum autoantibody and/or cytokine signature patterns can be utilized to monitor responses to therapy. Assessment of this signature pattern of autoantibodies and/or cytokines in a patient thus allows improved methods of care. In one embodiment of the invention, the autoimmune disease is rheumatoid arthritis.
    Type: Application
    Filed: November 20, 2015
    Publication date: May 26, 2016
    Inventors: WOLFGANG HUEBER, WILLIAM H. ROBINSON, LAWRENCE STEINMAN, PAUL J. UTZ, Mark C. Genovese
  • Publication number: 20160068585
    Abstract: The present invention provides compositions and methods for treating insulin-dependent diabetes mellitus in a subject comprising administration of a self-vector encoding and expressing human proinsulin.
    Type: Application
    Filed: May 1, 2014
    Publication date: March 10, 2016
    Inventors: Bart O. Roep, William H. Robinson, Paul Utz, Hideki Garren, Lawrence Steinman
  • Patent number: 9140701
    Abstract: Compositions and methods are provided for prognostic classification of rheumatoid arthritis disease patients into subtypes, which subtypes are informative of the patient's need for therapy and responsiveness to a therapy of interest.
    Type: Grant
    Filed: August 4, 2010
    Date of Patent: September 22, 2015
    Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: William H. Robinson, Peggy Pui-Kay Ho, Xiaoyan Zhao, Lawrence M. Steinman
  • Publication number: 20150133317
    Abstract: Disclosed herein are compositions and methods for sequencing, analyzing, and utilizing samples such as single samples. Also disclosed herein are compositions and methods for matching together two or more sequences from a sample. Also disclosed herein are compositions and methods for expressing and screening molecules of interest.
    Type: Application
    Filed: April 27, 2012
    Publication date: May 14, 2015
    Applicants: Department of Veterans Affairs, The Board of Trustees of the Leland Stanford Junior University
    Inventors: William H. Robinson, Yann Chong Tan, Jeremy Sokolove